Global Vinpocetine Market Size, Manufacturers, Opportunities and Forecast to 2030

Global Vinpocetine Market Size, Manufacturers, Opportunities and Forecast to 2030


Summary

Vinpocetine is a synthetic derivative of the vinca alkaloid vincamine, an extract from the lesser periwinkle plant. Vinpocetine was first isolated from the plant in 1975 by the Hungarian chemist Csaba Szántay. The mass production of the synthetic compound was started in 1978 by the Hungarian pharmaceutical company Richter Gedeon. The indications is improvement all symptoms of cerebral infarction and cerebral hemorrhage sequela, cerebrovascular atherosclerosis
Vinpocetine is not FDA approved in the United States for therapeutic use. The U.S. Food & Drug Administration (FDA) has ruled that vinpocetine, due to its synthetic nature and proposed therapeutic uses, was ineligible to be marketed as dietary supplement under the Federal Food, Drug, and Cosmetic Act (FDCA).

According to APO Research, The global Vinpocetine market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.

North American market for Vinpocetine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Vinpocetine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Vinpocetine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global manufacturers of Vinpocetine include Gedeon Richter, Runhong, Sun Pharma, WZT, PUDE, Welman, ZhiTong, Liaoning Zhiying and COVEX, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Vinpocetine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vinpocetine.
The Vinpocetine market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Vinpocetine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Gedeon Richter
Runhong
Sun Pharma
WZT
PUDE
Welman
ZhiTong
Liaoning Zhiying
COVEX
Northeast Pharma
Micro Labs
Vinpocetine segment by Type

Tablet
Injection
Vinpocetine segment by Application

Household
Hospital
Vinpocetine by Distribution Channel

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vinpocetine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Vinpocetine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vinpocetine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Vinpocetine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Vinpocetine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.


1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Vinpocetine Market Size Estimates and Forecasts (2019-2030)
1.2.2 Global Vinpocetine Sales Estimates and Forecasts (2019-2030)
1.3 Vinpocetine Market by Type
1.3.1 Tablet
1.3.2 Injection
1.4 Global Vinpocetine Market Size by Type
1.4.1 Global Vinpocetine Market Size Overview by Type (2019-2030)
1.4.2 Global Vinpocetine Historic Market Size Review by Type (2019-2024)
1.4.3 Global Vinpocetine Forecasted Market Size by Type (2025-2030)
1.5 Key Regions Market Size by Type
1.5.1 North America Vinpocetine Sales Breakdown by Type (2019-2024)
1.5.2 Europe Vinpocetine Sales Breakdown by Type (2019-2024)
1.5.3 Asia-Pacific Vinpocetine Sales Breakdown by Type (2019-2024)
1.5.4 Latin America Vinpocetine Sales Breakdown by Type (2019-2024)
1.5.5 Middle East and Africa Vinpocetine Sales Breakdown by Type (2019-2024)
2 Global Market Dynamics
2.1 Vinpocetine Industry Trends
2.2 Vinpocetine Industry Drivers
2.3 Vinpocetine Industry Opportunities and Challenges
2.4 Vinpocetine Industry Restraints
3 Market Competitive Landscape by Company
3.1 Global Top Players by Vinpocetine Revenue (2019-2024)
3.2 Global Top Players by Vinpocetine Sales (2019-2024)
3.3 Global Top Players by Vinpocetine Price (2019-2024)
3.4 Global Vinpocetine Industry Company Ranking, 2022 VS 2023 VS 2024
3.5 Global Vinpocetine Key Company Manufacturing Sites & Headquarters
3.6 Global Vinpocetine Company, Product Type & Application
3.7 Global Vinpocetine Company Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Vinpocetine Market CR5 and HHI
3.8.2 Global Top 5 and 10 Vinpocetine Players Market Share by Revenue in 2023
3.8.3 2023 Vinpocetine Tier 1, Tier 2, and Tier 3
4 Vinpocetine Regional Status and Outlook
4.1 Global Vinpocetine Market Size and CAGR by Region: 2019 VS 2023 VS 2030
4.2 Global Vinpocetine Historic Market Size by Region
4.2.1 Global Vinpocetine Sales in Volume by Region (2019-2024)
4.2.2 Global Vinpocetine Sales in Value by Region (2019-2024)
4.2.3 Global Vinpocetine Sales (Volume & Value), Price and Gross Margin (2019-2024)
4.3 Global Vinpocetine Forecasted Market Size by Region
4.3.1 Global Vinpocetine Sales in Volume by Region (2025-2030)
4.3.2 Global Vinpocetine Sales in Value by Region (2025-2030)
4.3.3 Global Vinpocetine Sales (Volume & Value), Price and Gross Margin (2025-2030)
5 Vinpocetine by Application
5.1 Vinpocetine Market by Application
5.1.1 Household
5.1.2 Hospital
5.2 Global Vinpocetine Market Size by Application
5.2.1 Global Vinpocetine Market Size Overview by Application (2019-2030)
5.2.2 Global Vinpocetine Historic Market Size Review by Application (2019-2024)
5.2.3 Global Vinpocetine Forecasted Market Size by Application (2025-2030)
5.3 Key Regions Market Size by Application
5.3.1 North America Vinpocetine Sales Breakdown by Application (2019-2024)
5.3.2 Europe Vinpocetine Sales Breakdown by Application (2019-2024)
5.3.3 Asia-Pacific Vinpocetine Sales Breakdown by Application (2019-2024)
5.3.4 Latin America Vinpocetine Sales Breakdown by Application (2019-2024)
5.3.5 Middle East and Africa Vinpocetine Sales Breakdown by Application (2019-2024)
6 Company Profiles
6.1 Gedeon Richter
6.1.1 Gedeon Richter Comapny Information
6.1.2 Gedeon Richter Business Overview
6.1.3 Gedeon Richter Vinpocetine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Gedeon Richter Vinpocetine Product Portfolio
6.1.5 Gedeon Richter Recent Developments
6.2 Runhong
6.2.1 Runhong Comapny Information
6.2.2 Runhong Business Overview
6.2.3 Runhong Vinpocetine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Runhong Vinpocetine Product Portfolio
6.2.5 Runhong Recent Developments
6.3 Sun Pharma
6.3.1 Sun Pharma Comapny Information
6.3.2 Sun Pharma Business Overview
6.3.3 Sun Pharma Vinpocetine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Sun Pharma Vinpocetine Product Portfolio
6.3.5 Sun Pharma Recent Developments
6.4 WZT
6.4.1 WZT Comapny Information
6.4.2 WZT Business Overview
6.4.3 WZT Vinpocetine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 WZT Vinpocetine Product Portfolio
6.4.5 WZT Recent Developments
6.5 PUDE
6.5.1 PUDE Comapny Information
6.5.2 PUDE Business Overview
6.5.3 PUDE Vinpocetine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 PUDE Vinpocetine Product Portfolio
6.5.5 PUDE Recent Developments
6.6 Welman
6.6.1 Welman Comapny Information
6.6.2 Welman Business Overview
6.6.3 Welman Vinpocetine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Welman Vinpocetine Product Portfolio
6.6.5 Welman Recent Developments
6.7 ZhiTong
6.7.1 ZhiTong Comapny Information
6.7.2 ZhiTong Business Overview
6.7.3 ZhiTong Vinpocetine Sales, Revenue and Gross Margin (2019-2024)
6.7.4 ZhiTong Vinpocetine Product Portfolio
6.7.5 ZhiTong Recent Developments
6.8 Liaoning Zhiying
6.8.1 Liaoning Zhiying Comapny Information
6.8.2 Liaoning Zhiying Business Overview
6.8.3 Liaoning Zhiying Vinpocetine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Liaoning Zhiying Vinpocetine Product Portfolio
6.8.5 Liaoning Zhiying Recent Developments
6.9 COVEX
6.9.1 COVEX Comapny Information
6.9.2 COVEX Business Overview
6.9.3 COVEX Vinpocetine Sales, Revenue and Gross Margin (2019-2024)
6.9.4 COVEX Vinpocetine Product Portfolio
6.9.5 COVEX Recent Developments
6.10 Northeast Pharma
6.10.1 Northeast Pharma Comapny Information
6.10.2 Northeast Pharma Business Overview
6.10.3 Northeast Pharma Vinpocetine Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Northeast Pharma Vinpocetine Product Portfolio
6.10.5 Northeast Pharma Recent Developments
6.11 Micro Labs
6.11.1 Micro Labs Comapny Information
6.11.2 Micro Labs Business Overview
6.11.3 Micro Labs Vinpocetine Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Micro Labs Vinpocetine Product Portfolio
6.11.5 Micro Labs Recent Developments
7 North America by Country
7.1 North America Vinpocetine Sales by Country
7.1.1 North America Vinpocetine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.1.2 North America Vinpocetine Sales by Country (2019-2024)
7.1.3 North America Vinpocetine Sales Forecast by Country (2025-2030)
7.2 North America Vinpocetine Market Size by Country
7.2.1 North America Vinpocetine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2.2 North America Vinpocetine Market Size by Country (2019-2024)
7.2.3 North America Vinpocetine Market Size Forecast by Country (2025-2030)
8 Europe by Country
8.1 Europe Vinpocetine Sales by Country
8.1.1 Europe Vinpocetine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.1.2 Europe Vinpocetine Sales by Country (2019-2024)
8.1.3 Europe Vinpocetine Sales Forecast by Country (2025-2030)
8.2 Europe Vinpocetine Market Size by Country
8.2.1 Europe Vinpocetine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2.2 Europe Vinpocetine Market Size by Country (2019-2024)
8.2.3 Europe Vinpocetine Market Size Forecast by Country (2025-2030)
9 Asia-Pacific by Country
9.1 Asia-Pacific Vinpocetine Sales by Country
9.1.1 Asia-Pacific Vinpocetine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.1.2 Asia-Pacific Vinpocetine Sales by Country (2019-2024)
9.1.3 Asia-Pacific Vinpocetine Sales Forecast by Country (2025-2030)
9.2 Asia-Pacific Vinpocetine Market Size by Country
9.2.1 Asia-Pacific Vinpocetine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2.2 Asia-Pacific Vinpocetine Market Size by Country (2019-2024)
9.2.3 Asia-Pacific Vinpocetine Market Size Forecast by Country (2025-2030)
10 Latin America by Country
10.1 Latin America Vinpocetine Sales by Country
10.1.1 Latin America Vinpocetine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.1.2 Latin America Vinpocetine Sales by Country (2019-2024)
10.1.3 Latin America Vinpocetine Sales Forecast by Country (2025-2030)
10.2 Latin America Vinpocetine Market Size by Country
10.2.1 Latin America Vinpocetine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2.2 Latin America Vinpocetine Market Size by Country (2019-2024)
10.2.3 Latin America Vinpocetine Market Size Forecast by Country (2025-2030)
11 Middle East and Africa by Country
11.1 Middle East and Africa Vinpocetine Sales by Country
11.1.1 Middle East and Africa Vinpocetine Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.1.2 Middle East and Africa Vinpocetine Sales by Country (2019-2024)
11.1.3 Middle East and Africa Vinpocetine Sales Forecast by Country (2025-2030)
11.2 Middle East and Africa Vinpocetine Market Size by Country
11.2.1 Middle East and Africa Vinpocetine Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2.2 Middle East and Africa Vinpocetine Market Size by Country (2019-2024)
11.2.3 Middle East and Africa Vinpocetine Market Size Forecast by Country (2025-2030)
12 Value Chain and Sales Channels Analysis
12.1 Vinpocetine Value Chain Analysis
12.1.1 Vinpocetine Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Vinpocetine Production Mode & Process
12.2 Vinpocetine Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Vinpocetine Distributors
12.2.3 Vinpocetine Customers
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings